PGT Innovations Valuation
Is P9I undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of P9I when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: P9I (€38.6) is trading below our estimate of fair value (€45.23)
Significantly Below Fair Value: P9I is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for P9I?
Key metric: As P9I is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is P9I's PE Ratio? | |
|---|---|
| PE Ratio | 22.8x |
| Earnings | US$107.40m |
| Market Cap | US$2.45b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.1x |
| Enterprise Value/EBITDA | 12.8x |
| PEG Ratio | 1.1x |
Price to Earnings Ratio vs Peers
How does P9I's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 14.6x | ||
VIB3 Villeroy & Boch | 14.4x | 43.5% | €407.1m |
ST5 STEICO | 9.6x | -7.6% | €266.2m |
WUG Westag | 24.1x | n/a | €117.0m |
TSS InnoTec TSS | 10.2x | n/a | €58.4m |
P9I PGT Innovations | 22.8x | 19.9% | €2.4b |
Price-To-Earnings vs Peers: P9I is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the peer average (20.9x).
Price to Earnings Ratio vs Industry
How does P9I's PE Ratio compare vs other companies in the European Building Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: P9I is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the European Building industry average (16.2x).
Price to Earnings Ratio vs Fair Ratio
What is P9I's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 22.8x |
| Fair PE Ratio | 19.4x |
Price-To-Earnings vs Fair Ratio: P9I is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the estimated Fair Price-To-Earnings Ratio (19.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Nov ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Oct ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Sep ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Aug ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Jul ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Jun ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| May ’25 | n/a | €38.18 0% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Apr ’25 | €38.60 | €38.18 -1.1% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Mar ’25 | €38.60 | €38.18 -1.1% | 6.6% | €41.27 | €34.23 | n/a | 4 |
| Feb ’25 | €38.20 | €37.94 -0.7% | 6.6% | €41.01 | €34.00 | n/a | 4 |
| Jan ’25 | €37.20 | €35.72 -4.0% | 5.5% | €38.47 | €33.89 | n/a | 3 |
| Dec ’24 | €29.40 | €34.28 +16.6% | 6.2% | €36.38 | €30.78 | n/a | 4 |
| Nov ’24 | €28.20 | €33.68 +19.4% | 5.4% | €35.80 | €31.09 | n/a | 4 |
| Oct ’24 | €26.20 | €30.03 +14.6% | 10.9% | €33.80 | €25.12 | n/a | 4 |
| Sep ’24 | €25.80 | €30.03 +16.4% | 10.9% | €33.80 | €25.12 | n/a | 4 |
| Aug ’24 | €26.00 | €29.17 +12.2% | 11.5% | €32.96 | €24.05 | n/a | 4 |
| Jul ’24 | €26.80 | €29.50 +10.1% | 9.3% | €32.52 | €25.09 | n/a | 4 |
| Jun ’24 | €23.20 | €28.04 +20.9% | 8.5% | €30.34 | €24.82 | n/a | 4 |
| May ’24 | €23.00 | €26.59 +15.6% | 14.0% | €30.12 | €21.45 | n/a | 4 |
| Apr ’24 | €20.80 | €25.20 +21.2% | 7.7% | €27.19 | €22.04 | €38.60 | 4 |
| Mar ’24 | €19.80 | €24.03 +21.4% | 16.3% | €27.20 | €17.35 | €38.60 | 4 |
| Feb ’24 | €19.80 | €23.40 +18.2% | 15.8% | €27.01 | €17.23 | €38.20 | 4 |
| Jan ’24 | €16.90 | €24.60 +45.6% | 17.4% | €28.25 | €17.42 | €37.20 | 4 |
| Dec ’23 | €18.80 | €25.96 +38.1% | 15.9% | €29.81 | €19.23 | €29.40 | 4 |
| Nov ’23 | €20.80 | €26.61 +27.9% | 12.8% | €29.68 | €21.50 | €28.20 | 4 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Stabilus
€811.4m
Engages in the manufacture and sale of gas springs, dampers, vibration isolation products, and electric tailgate opening and closing equipment in Europe, the Middle East, Africa, North and South America, the Asia-Pacific, and internationally.
STM
€32.85
7D
0.6%
1Y
-42.8%
Alfa. de
Mex$83.3b
Engages in the petrochemical and synthetic fiber and refrigerated food businesses in Mexico.
G4L
Mex$0.64
7D
-1.5%
1Y
5.8%
DAIHEN
JP¥169.6b
Manufactures and sells transformers, welding machines, and industrial and clean transport robots.
6NV
JP¥43.40
7D
2.8%
1Y
21.2%